Carlo Guglielmo Cattaneo1, Daniela Musio1, Federica Tanzi2, Giacomo Guidi2, Innocenza Palaia2, Vincenzo Tombolini1, Francesca DE Felice3. 1. Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy. 2. Department of Maternal and Child Health and Urological Sciences, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy. 3. Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy; fradefelice@hotmail.it.
Abstract
BACKGROUND: This is the case report of a synchronous anal canal cancer and cervical cancer in a patient who underwent definitive chemoradiotherapy (CRT) and radical surgery for anal canal and cervical carcinoma, respectively. CASE REPORT: A 55-year-old woman was diagnosed with cT4a cN1 Mx anal canal squamous cell carcinoma and stage IA2 cervical squamous cell carcinoma, based on biopsy and imaging. Definitive CRT consisted of radiotherapy (total dose of 59.4 Gy) and concomitant mitomycin (10 mg/m2) and 5-fluorouracil (750 mg/m2/5 daily continuous infusion) during the first and last week of radiation. The patient exhibited a complete clinical and radiological response. A radical hysterectomy with pelvic lymphadenectomy was then performed. At the last follow-up (30 months), the patient is still disease-free without any treatment-associated complications. CONCLUSION: There is limited information in the literature regarding treatment strategy and outcome of patients with synchronous anal canal and cervical cancer. A two-step treatment, including CRT and radical hysterectomy, is likely to be accepted as valid option.
BACKGROUND: This is the case report of a synchronous anal canal cancer and cervical cancer in a patient who underwent definitive chemoradiotherapy (CRT) and radical surgery for anal canal and cervical carcinoma, respectively. CASE REPORT: A 55-year-old woman was diagnosed with cT4a cN1 Mx anal canal squamous cell carcinoma and stage IA2 cervical squamous cell carcinoma, based on biopsy and imaging. Definitive CRT consisted of radiotherapy (total dose of 59.4 Gy) and concomitant mitomycin (10 mg/m2) and 5-fluorouracil (750 mg/m2/5 daily continuous infusion) during the first and last week of radiation. The patient exhibited a complete clinical and radiological response. A radical hysterectomy with pelvic lymphadenectomy was then performed. At the last follow-up (30 months), the patient is still disease-free without any treatment-associated complications. CONCLUSION: There is limited information in the literature regarding treatment strategy and outcome of patients with synchronous anal canal and cervical cancer. A two-step treatment, including CRT and radical hysterectomy, is likely to be accepted as valid option.
Authors: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Jordan D Berlin; J Michael Berry; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Eric Rohren; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; William Small; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett Journal: J Natl Compr Canc Netw Date: 2010-01 Impact factor: 11.908
Authors: C Chargari; K Peignaux; A Escande; S Renard; C Lafond; A Petit; D Lam Cham Kee; C Durdux; C Haie-Méder Journal: Cancer Radiother Date: 2021-12-23 Impact factor: 1.018
Authors: Claudia Marchetti; Francesca De Felice; Anna Di Pinto; Alessia Romito; Angela Musella; Innocenza Palaia; Marco Monti; Vincenzo Tombolin; Ludovico Muzii; PierLuigi Benedetti Panici Journal: Cancer Res Treat Date: 2017-07-19 Impact factor: 4.679